高级检索
当前位置: 首页 > 详情页

Microbubble contrast agent SonoVue combined with oxytocin improves the efficiency of high-intensity focused ultrasound ablation for adenomyosis

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Medical Imaging Department, The First Affiliated Hospital of Kunming Medical University, Kunming, China
出处:
ISSN:

关键词: Adenomyosis high-intensity focused ultrasound SonoVue oxytocin ablation

摘要:
Background To investigate the combined enhancing effects of microbubble-contrast SonoVue and oxytocin on high-intensity focused ultrasound (HIFU) ablation of adenomyosis. Methods 330 patients with adenomyosis were randomly assigned to SonoVue and oxytocin group (group A, n = 82), oxytocin (group B, n = 85), SonoVue (group C, n = 81), or the control (group D, n = 82) for HIFU ablation. In group A, oxytocin was dripped 0.32 IU/min, and HIFU ablation was started one minute after SonoVue injection. In group B, oxytocin was dripped 0.32 IU/min during ablation. In group C, HIFU ablation was started one minute after SonoVue injection. In group D, neither oxytocin nor SonoVue was applied. The clinical data, treatment results, and complications were analyzed. Results All participants underwent HIFU treatment safely, and the mean energy efficiency factor (EEF) in the four groups was 4.7 +/- 0.9J/mm(3), 8.5 +/- 0.6J/mm(3), 8.9 +/- 0.7J/mm(3), and 12.6 +/- 1.8J/mm(3), respectively, with the mean ablation time (AT) of 633.7 +/- 55.1 s, 874.2 +/- 65.6 s, 936.3 +/- 85.2 s, and 1103.2 +/- 96.2 s, respectively. The non-perfused volume ratios (NPVR) were 90.4 +/- 8.8%, 88.7 +/- 9.1%, 89.4 +/- 7.2%, 80.5 +/- 7.9%, respectively. In addition, EEF and AT were the shortest in group A (p < 0.05). NPVR was significantly higher in group A than in the control group D (p < 0.05). The incidence rates of adverse events were not significantly different in the four groups (p > 0.05). Conclusions Compared to the control group, oxytocin combined with SonoVue in HIFU for adenomyosis can significantly decrease the energy and time needed for the ablation and safely enhance the treatment efficiency by improving the cavitation and heating of HIFU ablation and increasing the non-perfused volume ratio.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
大类 | 2 区 医学
小类 | 3 区 核医学 3 区 肿瘤学
最新[2023]版:
大类 | 3 区 医学
小类 | 3 区 肿瘤学 3 区 核医学
JCR分区:
出版当年[2021]版:
Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Q3 ONCOLOGY
最新[2023]版:
Q2 ONCOLOGY Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

影响因子: 最新[2023版] 最新五年平均 出版当年[2021版] 出版当年五年平均 出版前一年[2020版] 出版后一年[2022版]

第一作者:
第一作者机构: [1]Medical Imaging Department, The First Affiliated Hospital of Kunming Medical University, Kunming, China
通讯作者:
通讯机构: [1]Medical Imaging Department, The First Affiliated Hospital of Kunming Medical University, Kunming, China [*1]Medical Imaging Department, The First Affiliated Hospital of Kunming Medical University, Kunming, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:52537 今日访问量:0 总访问量:1562 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 昆明医科大学第一附属医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西昌路295号(650032)